Modified GLP-1 Peptide Analog
Semaglutide is a modified GLP-1 receptor agonist peptide analog.
Product Procurement
Research-use catalog items with clear ordering, product context, and documentation support.
Semaglutide — 30mg
$89.99
Product estimate
- FORMAT
- Lyophilized Powder
- NET VIAL CONTENT
- 30mg
- CATEGORY
- Peptides
- SKU
- ALS-SEMA-30MG
In stock
Research Use Notice
For laboratory research use only. Not for human or animal use or consumption. Not for diagnostic, therapeutic, or veterinary use. Product documentation and certificates of analysis do not establish safety or suitability for these uses.
Product Intelligence
Semaglutide Receptor & Peptide Profile
Modified GLP-1 receptor agonist peptide analog supplied as 30mg lyophilized semaglutide research material.
30mg Lyophilized Research Material
Supplied as 30mg lyophilized semaglutide research material.
GLP-1 Receptor / Incretin Pathway
Semaglutide is associated with GLP-1 receptor pharmacology and incretin-pathway studies in receptor-pathway research.
- ClassModified GLP-1 receptor agonist peptide analog
- IdentifierPubChem CID 56843331
- CAS910463-68-2
- Presentation30mg lyophilized material
Documentation
Verification & Documentation
Documentation is handled by product and lot. Use Standards to search for a matching record; if none appears, contact support with the product name, SKU, and lot number.